As a response to the recent coronavirus outbreak, Enantis joined the international efforts and became a member of FASTCURE consortium (https://fastcure.net/).
The goal of this initiative is to employ structural targeting of coronavirus using repurposing and efficient diagnostics. Enantis will contribute with computational analysis of protein-ligand complexes, compound transport process analysis, prediction of disease-related mutations and identification of mutagenesis hotspots.
The lessons learned, the data management system and automated workflows, from the genome to the drug candidates, will be made available as a cloud-based, distributed, global emergency response system to ensure an immediate and well-coordinated response not only to COVID-19, but also to future outbreaks.